# Topographic associations of hyperreflective materials in diabetic retinopathy: a multimodal correlation with microvascular pathology, structural remodeling and systemic metabolic dysregulation

**Authors:** Lan Zhou, Hongyan Sun, Cunzi Li, Tianyi Luo, Ting Meng, Xiaojun Wen, Zilin Chen, Yan Hu, Ming-Ming Yang

PMC · DOI: 10.3389/fmed.2025.1619819 · Frontiers in Medicine · 2025-07-16

## TL;DR

This study explores how hyperreflective materials in diabetic retinopathy are linked to retinal vascular changes and metabolic factors.

## Contribution

The study identifies six distinct hyperreflective material subtypes and their spatial associations with retinal vascular and metabolic features in diabetic retinopathy.

## Key findings

- Six distinct hyperreflective material phenotypes were identified and mapped to retinal vascular abnormalities.
- Hyperreflective materials were predominantly found in areas of intraretinal microvascular abnormalities and non-perfusion zones.
- Dyslipidemia was identified as a strong predictor of hyperreflective material burden in diabetic retinopathy.

## Abstract

Hyperreflective materials (HRMs), enigmatic biomarkers observed in diabetic retinopathy (DR), exhibit poorly characterized pathophysiological origins and clinical implications.

This retrospective cross-sectional study investigates the spatial distribution patterns of HRMs subtypes and their integrative relationships with retinal microvascular architecture, structural remodeling, and systemic metabolic parameters in 205 DR eyes. HRMs were systematically classified via multimodal optical coherence tomography angiography (OCTA) analysis, incorporating topographic localization (inner vs. outer retinal), reflectivity profiles, morphometric dimensions, posterior shadowing artifacts, and decorrelation signal. Quantitative correlations were established between HRMs subtypes and OCTA-derived vascular parameters (intraretinal microvascular abnormalities [IRMA], non-perfusion [NP] areas, microaneurysms), diabetic macular edema (DME) status, and systemic metabolic indices (glycemic control, lipid profiles, renal function, inflammatory markers).

Six distinct HRMs phenotypes were identified: inner retinal hyperreflective spots (IRHFs), outer retinal hyperreflective spots (ORHFs), intraretinal hard exudates (IRHE), outer retinal hard exudates (ORHE), decorrelation-positive HRMs, and cotton-wool spots. Spatial mapping revealed predominant HRMs colocalization with IRMA territories (75.4% IRHFs, 89.5% ORHFs, 90.8% IRHE, 94% ORHE), while 19% of IRHFs and 8.7% of ORHFs overlapped NP zones. Decorrelation-positive HRMs demonstrated dual associations with IRMA (77.6%) and microaneurysms (21.0%). DME eyes exhibited significantly elevated HRMs density within IRMA and NP regions (P < 0.001). Multivariate analysis identified dyslipidemia as a strong predictor of HRMs burden.

These findings establish HRMs as spatially resolved biomarkers of diabetic retinal pathophysiology, reflecting compartment specific interactions between microvascular incompetence (IRMA-associated barrier failure), ischemic remodeling (NP zones), and systemic metabolic dysregulation. The colocalization of HRMs subtypes with IRMA walls and leakage-prone microaneurysms supports their putative role as optical signatures of lipoprotein extravasation and inflammatory lipidotoxicity in DR progression.

## Linked entities

- **Diseases:** diabetic retinopathy (MONDO:0005266), diabetic macular edema (MONDO:0004728), dyslipidemia (MONDO:0002525)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** metabolic dysfunction (MESH:D008659), AMD (MESH:D008268), inflammation (MESH:D007249), ORHE (MESH:D012173), DME (MESH:D008269), uveitis (MESH:D014605), NPDR (OMIM:603933), edema (MESH:D004487), IRMA (MESH:D006949), serous (MESH:D018297), DM (MESH:D009223), microaneurysms (MESH:D000071071), lipid (MESH:D011017), cataract (MESH:D002386), retinal vein occlusion (MESH:D012170), glucose (MESH:D018149), vitreous hemorrhage (MESH:D014823), type 1 or 2 diabetes mellitus (MESH:D003924), retinal neovascular membranes (MESH:D015861), DR (MESH:D003930), vascular abnormalities (MESH:D014652), retinopathies (MESH:D058437), IRHE (MESH:D018804), diabetes (MESH:D003920), hypertension (MESH:D006973), hypoxic (MESH:D002534), ischemic (MESH:D002545), dyslipidemia (MESH:D050171), intra-retinal microvascular abnormalities (MESH:D012164), CL (MESH:D002971), retinal detachment (MESH:D012163), media opacities (MESH:D003318), microvascular disorder (MESH:D017566)
- **Chemicals:** steroid (MESH:D013256), Fluorescein (MESH:D019793), Lipid (MESH:D008055), triglyceride (MESH:D014280), IRHFs (-), fenofibrate (MESH:D011345), TG (MESH:D013866), creatinine (MESH:D003404), TC (MESH:D013667), glucose (MESH:D005947), cholesterol (MESH:D002784)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307468/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12307468/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307468/full.md

---
Source: https://tomesphere.com/paper/PMC12307468